Top Markets
#1 MowCat MowCat +48.51%
#2 Bitway Bitway +28.60%
#3 Velvet Velvet +25.02%
#4 Fake World Assets Fake World Assets +24.70%
#5 aPriori aPriori +24.35%
#6 OVERTAKE OVERTAKE +20.74%
#7 Zerebro Zerebro +17.04%
#8 Verus Coin Verus Coin +16.08%
#9 Derive Derive +14.93%
#10 Biconomy Biconomy +13.92%
Coin of the day
MowCat MowCat
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
शेयरों में रैंक #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
शेयर मूल्य
$0.04895618
अंतिम समन्वयन: 2025-03-18
मार्केट कैप
$5.55M
बदलाव (1 दिन)
-0.04%
बदलाव (1 वर्ष)
0.00%
देश
CA
व्यापार WPD Pharmaceuticals Inc. (WBIO)

श्रेणी

Healthcare
WPD Pharmaceuticals Inc. (WBIO) के लिए P/B अनुपात
2026 को P/B अनुपात TTM: 0
WPD Pharmaceuticals Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/B अनुपात 0 था।
WPD Pharmaceuticals Inc. के लिए 2026 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE